<DOC>
	<DOC>NCT00147160</DOC>
	<brief_summary>The purpose of this study is to determine whether the combination of Temozolomide and Cisplatinum is effective in the treatment of malignant glial tumours of children and adolescents</brief_summary>
	<brief_title>Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Age from 4th birthday and younger than 21st birthday Histologically documented malignant glial tumour (WHO classification grade III and IV) : astrocytoma, oligodendroglioma, oligoastrocytoma and mixed tumours Measurable and evaluable disease by the imaging criteria (MRI) Patient not previously treated by either of the two drugs Malignant brain stem tumours are excluded</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>